Author

Jennifer Walker-Journey

5333 posts

Jennifer Walker-Journey is a professional writer whose 20-year career spans from newspapers and magazines to Ezines and business blogs. Her primary focus is corporate and business writing, though she relishes any opportunity to write features. In her limited free time, Jennifer strives to finish the novel she is writing. She lives in Birmingham with her husband, Rick, and their insatiably curious son, Truman.

FDA investigating deaths, illnesses possibly related to dietary supplement

Blue pills

The Food and Drug Administration (FDA) is investigating two fatalities and reports of two children with elevated levels of lead who may have consumed DHZC-2 dietary supplements manufactured by Ton Shen/Life Rising. The agency is also investigating other products made by the company for the presence of lead and other hazardous materials. The FDA tested product samples at the Ton Shen Health/Life Rising retail location in the Chicago metropolitan area in response to an adverse event report. The agency’s analysis confirmed that samples contained 56 times the amount of lead above that which would pose a health risk for children, ... Read More

FDA may be making same deadly mistake it made approving power morcellators

morcellator

Philadelphia-area doctors and husband-and-wife advocates Hoosman Noorchashm, M.D., Ph.D., and Amy J. Reed, M.D., Ph.D., published an editorial in The Inquirer Daily News warning that the Food and Drug Administration (FDA), in approving a new device, may be repeating the same deadly mistake it made when it approved the use of power morellation for hysterectomies and myomectomies. Power morcellators are surgical tools fitted with tube-like blades that shred uterine growths or entire uteruses within the abdomen and remove the tissue through a small incision in the belly. The procedure has been preferred in recent years to open surgery because it ... Read More

Women who claim they were injured by Essure fighting for their day in court

Essure

Becky Beesley struggles not to cry when she thinks back on the day in 2012 that she decided to get the Essure permanent birth control. “Immediately my body rejected the procedure,” she told ABC 15 News. “My leg started to tremor and I threw up a couple of times.” Within a few months, serious health issues began to emerge. “I felt like there were little gremlins…that were just trying to claw their way out.” She says the pain became so excruciating, she had to quit her teaching job. Her doctor finally removed the implant, but the pain persisted. Beesley saw ... Read More

First four lawsuits set the stage for Xarelto bleeding events litigation

xarelto

Joseph Boudreaux was prescribed the blood thinner Xarelto, but a month later he began bleeding internally so badly that he was hospitalized and required several blood transfusions. Joseph Orr’s wife used Xarelto for about a month before she died from a brain hemorrhage. Dora Mingo took Xarelto after developing blood clots, but had to discontinue treatment after she began bleeding in her gastrointestinal tract. William Henry died from a gastrointestinal bleed after taking Xarelto to prevent strokes associated with his heart condition, atrial fibrillation. These are the first four cases set to go to trial among more than 7,200 in a ... Read More

TBIs early in life linked to psychiatric problems, premature death

skull xray

Children and young adults who suffer even a mild head trauma are more likely to have to die early and have problems functioning as adults, according to a study conducted by researchers with the University of Oxford in England. The study compared 100,000 Swedes who had suffered a traumatic brain injury (TBI) before the age of 25 with their siblings, who had not suffered a TBI. Researchers found that those with head injuries were more likely to have psychiatric problems later in life and suffer a premature death. The effects of a TBI were more prominent in those who were older ... Read More

FDA warns of problems with low-rate infusion with programmable syringe pumps

fda-logo

Using programmable syringe pumps to infuse therapies at low rates may result in an inconsistent rate of delivery, which can lead to serious clinical consequences, including delay of therapy, over-infusion, or under-infusion, the Food and Drug Administration (FDA) warned health care professionals in a Safety Alert. Reports of serious adverse events such as abnormal or unstable blood pressure, anxiety from loss of sedation, and increased pain indicators in critically ill infants have been associated with this lack of flow continuity. Programmable syringe pumps deliver solutions such as fluids, medications, or blood products to patients. They are capable of delivering at low infusion ... Read More

Sales of diabetes drug Invokana expected to climb despite new side effects warnings

Invokana

The global market for diabetes and obesity treatments is expected to rise from $70.8 billion in 2015 to $163.2 billion by 2022, according to business intelligence firm GBI research. One of the drugs named as a key player with a great shot at reaching blockbuster status is Johnson & Johnson and Janssen Pharmaceuticals’ type 2 diabetes drug Invokana. Analysts say that sales of Invokana could reach $3.23 billion by 2022. Sales will be boosted by the obesity epidemic and a growing number of the population being diagnosed with type 2 diabetes. Invokana’s makers are also looking at expanding the drug’s ... Read More

Power morcellation procedures decline following FDA cancer-spread warning

morcellator

The use of power morcellators for hysterectomies and myomectomies (uterine fibroid removal) has decreased significantly since the Food and Drug Administration (FDA) warned two years ago that the devices could cause the spread of undiagnosed uterine cancer, worsening a woman’s odds of survival. Power morcellators are surgical tools fitted with a tube-like blade that shreds uterine growths or entire uteruses within the body and removes the tissue through a small incision in the abdomen. The procedure has been preferred over open surgery because it is less invasive and there is less risk of infection. Plus, it greatly reduces recovery time. ... Read More

Anti-seizure drug Lamotrigine ODT recalled due to packaging error

fda-logo

Impax Labs is recalling a single lot of the anti-seizure drug Lamotrigine Orally Disintegrating Tablets (ODT) because the childproof shell-packs labeled 200 mg may only contain 100 mg blister cards. Lamotrigine ODT is a phenyltriazine drug used as an adjunct to treat partial seizures, Lennox-Gastaut syndrome, or primary generalized tonic-clonic seizures in adults and children 2 years of age and older. It is also used as a conversion to monotherapy in adults 16 years and older with partial seizures who are on carbamazepine, phenytoin, phenobarbital, primidone, or valproate as a single antiepileptic drug (AED). Lamotrigine is also used as a ... Read More

Study shows increased leg and foot amputations with Invokana, Invokamet

Invokana

A clinical trial assessing heart risk with the newer type 2 diabetes drug canagliflozin, found in the brand-name drugs Invokana and Invokamet, found that patients who used the medication were at an increased risk of leg and foot amputations. The ongoing CANVAS (Canagliflozin Cardiovascluar Assessment Study) was launched four and a half years ago and continues to be evaluated by an independent data monitoring committee. Seven out of every 1,000 patients were treated with 100 mg of canagliflozin daily, five out of every 1,000 were treated with 300 mg daily, and three out of every 1,000 were given a placebo. A one-year ... Read More